Your session is about to expire
← Back to Search
Smartphone-Assisted Relapse Prevention for Substance Use Disorder (SARC-YA Trial)
N/A
Recruiting
Led By Michael L Dennis, Ph.D.
Research Sponsored by Chestnut Health Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 18 to 26 at the time of discharge
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months sfs minus 6 month sfs
Awards & highlights
SARC-YA Trial Summary
This trial will test whether providing young adults in outpatient treatment for substance abuse with a smartphone, data plan, and access to recovery-focused applications will help them to stay away from substance abuse better than without the phone.
Who is the study for?
This trial is for young adults aged 18-26 who are being discharged from outpatient substance use disorder treatment and have used substances within the last 90 days. They must be able to read and communicate in English and plan to stay in Chicago for the next 9 months.Check my eligibility
What is being tested?
The study compares usual recovery support with a new method using smartphones (SARC-YA) after treatment discharge. Participants will get a smartphone, data plan, apps for daily assessments, feedback, behavioral tracking, and self-help tools to prevent relapse.See study design
What are the potential side effects?
There may not be traditional medical side effects; however, participants might experience stress or anxiety from constant monitoring or reliance on digital devices which could impact their mental health.
SARC-YA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 26 years old.
SARC-YA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months sfs minus 6 month sfs
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months sfs minus 6 month sfs
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in GAIN's Substance Frequency Scale from baseline to 6 months (effect of providing the intervention)
Secondary outcome measures
Change in European Quality of Life 5 dimensions (EQ5D) from baseline to 6 months
Change in GAIN Risk Behavior Screener (RBScr) from baseline to 6 months
Change in GAIN Substance Disorder Screener (SDScr) from baseline to 6 months
+4 moreSARC-YA Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smartphone Addiction Recovery Coach (SARC) - Assisted Relapse PreventionExperimental Treatment1 Intervention
Participants in the experimental condition will receive a smartphone, a calling/texting/data plan, and the SARC-YA mobile applications for the first 6 months post treatment discharge. Experimental participants will 1) complete a 2-3 minute recovery-focused ecological momentary assessment (EMA) at 5 random times a day, receive feedback on their current answers, and provided access to behavioral charting of their past answers over time; and 2) receive continuous access to a suite of self-initiated ecological momentary interventions (EMI) to support their recovery via tool box of coping tools, apps related to getting support, and apps related to maintaining a healthy lifestyle.
Group II: Recovery Support as Usual ControlActive Control2 Interventions
Participants in the control and experimental condition will have access to post treatment recovery support services as usual.
Find a Location
Who is running the clinical trial?
Chestnut Health SystemsLead Sponsor
21 Previous Clinical Trials
23,065 Total Patients Enrolled
Michael L Dennis, Ph.D.Principal InvestigatorChestnut Health Systems
2 Previous Clinical Trials
1,285 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot read or communicate in English.You have used drugs or alcohol in the 3 months before the study.I am between 18 and 26 years old.I am between 18 and 26 years old.You have used drugs or alcohol in the 3 months before starting the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Smartphone Addiction Recovery Coach (SARC) - Assisted Relapse Prevention
- Group 2: Recovery Support as Usual Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is eligibility for this medical experiment restricted to persons under the age of 75?
"According to the requirements for this clinical trial, only participants aged 18-26 will be accepted. However, there are 81 studies open for those younger than that age and 255 available for seniors over 65."
Answered by AI
What sort of individuals are the ideal participants for this research?
"To be considered for inclusion in this research study, candidates must present with substance use disorder (SUD) and fall between 18-26 years of age. The trial is looking to enrol a total of 300 participants."
Answered by AI
Are there any open vacancies in this clinical research endeavor?
"Affirmative. Per the details posted on clinicaltrials.gov, this trial was first launched on October 30th 2020 and is currently enrolling 300 patients at 2 locations. The record was last updated on April 6th 2022."
Answered by AI
How many participants can this experiment accommodate?
"Affirmative, the clinicaltrials.gov entry for this research illustrates that it is actively searching for participants who meet its criteria. Initially posted on October 30th 2020 and recently amended on April 6th 2022, the trial aims to enrol 300 patients across 2 centres."
Answered by AI
Who else is applying?
What state do they live in?
Florida
Tennessee
How old are they?
18 - 65
What site did they apply to?
Chestnut Health Systems
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
How responsive is this trial?
Typically responds via
Email
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger